Evidence map›Paper›PMID 41897628›Full record

ArticleDiagnostics (Basel, Switzerland)2026

Can Tc-99m-PSMA SPECT/CT Be Used as Accessible Alternative for Diagnosis of Biochemically Recurrent Prostate Cancer? A Prospective Study.

Veljković Miloš, Beatović Slobodanka, Pejčić Tomislav, Bukumirić Zoran, Odalović Strahinja, Grozdić Milojević Isidora, Stojiljković Milica, Petrović Jelena, Ivanovski Ana, Šobić Šaranović Dragana and 1 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Veljković MilošCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-8463-5932
Beatović SlobodankaCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Pejčić TomislavFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Bukumirić ZoranFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-7609-4504
Odalović StrahinjaCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Grozdić Milojević IsidoraCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0003-3301-9456
Stojiljković MilicaCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-7170-4433
Petrović JelenaCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-7168-8848
Ivanovski AnaCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0009-0000-3993-7114
Šobić Šaranović DraganaCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-9600-090X
Artiko VeraCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-6078-4500

Funding

Ministry of Science, Technological developments and Innovations of Republic of Serbia. 451-03-137/2025-03/ 200110
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biochemical recurrenceprostate cancerTc-99m-PSMA SPECT/CT

Identifiers

PMID41897628
PMCPMC13025446

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.